The effect of pre-operative Ramipril treatment on vascular inflammation in the abdominal aneurysm
- Conditions
- An aneurysm of the abdominal aortaMedDRA version: 8.1Level: LLTClassification code 10002882Term: Aortic aneurysm
- Registration Number
- EUCTR2006-006105-86-NL
- Lead Sponsor
- MC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Elective aneurysm repair operation
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Hypotension
Renal artery stenosis
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To test whether Ramipril, via its presumed effects on NFkB activation, reduces vascular inflammation in the abdominal aneurysm.;Secondary Objective: Te test whether Ramipril reduces protease activity in the abdominal aneurysm;Primary end point(s): NFkB activation in the aortic wall<br>IL-6 and 8 expression in the aortic wall
- Secondary Outcome Measures
Name Time Method